Many prescribers avoid this concentration for dose initiation and reserve it for patients already stabilized at 7.5 mg or above
Sedenho-Prado LG, Yugar LBT, Whitaker AR, Martins MP, Jesus DC, Ferreira I, et al
Conclusion GLP-1 receptor agonists have fundamentally reshaped obesity treatment by enabling unprecedented pharmacological weight loss
Now, this new test provides consumers with insights into gut health that were previously available only in research or clinical settings
Limiting high-fat, greasy, or very large meals can help reduce common digestive side effects
The body mistakenly thinks it's starving, activating hormones that increase fat storage